JP2022513888A5 - - Google Patents
Info
- Publication number
- JP2022513888A5 JP2022513888A5 JP2021534270A JP2021534270A JP2022513888A5 JP 2022513888 A5 JP2022513888 A5 JP 2022513888A5 JP 2021534270 A JP2021534270 A JP 2021534270A JP 2021534270 A JP2021534270 A JP 2021534270A JP 2022513888 A5 JP2022513888 A5 JP 2022513888A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024159011A JP2024175026A (ja) | 2018-12-14 | 2024-09-13 | Ｉｌ－１５組成物およびその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779793P | 2018-12-14 | 2018-12-14 | |
| US62/779,793 | 2018-12-14 | ||
| PCT/US2019/066287 WO2020123980A1 (en) | 2018-12-14 | 2019-12-13 | Il-15 compositions and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024159011A Division JP2024175026A (ja) | 2018-12-14 | 2024-09-13 | Ｉｌ－１５組成物およびその使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022513888A JP2022513888A (ja) | 2022-02-09 |
| JPWO2020123980A5 JPWO2020123980A5 (https=) | 2022-12-06 |
| JP2022513888A5 true JP2022513888A5 (https=) | 2022-12-06 |
| JP7557465B2 JP7557465B2 (ja) | 2024-09-27 |
Family
ID=71075819
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534270A Active JP7557465B2 (ja) | 2018-12-14 | 2019-12-13 | Ｉｌ－１５組成物およびその使用方法 |
| JP2024159011A Pending JP2024175026A (ja) | 2018-12-14 | 2024-09-13 | Ｉｌ－１５組成物およびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024159011A Pending JP2024175026A (ja) | 2018-12-14 | 2024-09-13 | Ｉｌ－１５組成物およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230045048A1 (https=) |
| EP (1) | EP3893917A4 (https=) |
| JP (2) | JP7557465B2 (https=) |
| KR (1) | KR102911817B1 (https=) |
| CN (1) | CN114746105A (https=) |
| AU (1) | AU2019395266A1 (https=) |
| CA (1) | CA3121813A1 (https=) |
| WO (1) | WO2020123980A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| CN120463822A (zh) | 2018-09-27 | 2025-08-12 | 西里欧发展公司 | 掩蔽型细胞因子多肽 |
| MX2022007202A (es) * | 2019-12-13 | 2022-10-07 | Cugene Inc | Fármacos bioactivables a base de citocinas y metodos de uso de los mismos. |
| AU2021254283B2 (en) | 2020-04-10 | 2025-12-11 | Cytomx Therapeutics, Inc. | Activatable cytokine constructs and related compositions and methods |
| WO2021257808A2 (en) * | 2020-06-17 | 2021-12-23 | Proviva Therapeutics (Hong Kong) Limited | Antibodies to fibroblast activation protein and b7h3 |
| WO2022115865A2 (en) | 2020-11-25 | 2022-06-02 | Xilio Development, Inc. | Tumor-specific cleavable linkers |
| JP2024511387A (ja) | 2021-03-16 | 2024-03-13 | シートムエックス セラピューティクス，インコーポレイテッド | マスクした活性化可能サイトカイン構成体ならびに関連する組成物及び方法 |
| US20240228585A1 (en) * | 2021-05-03 | 2024-07-11 | President And Fellows Of Harvard College | Fc-fusion protein therapeutic for the treatment of pancreatitis |
| EP4580683A2 (en) * | 2022-08-31 | 2025-07-09 | Proviva Therapeutics (Hong Kong) Limited | Il-15 procytokine antibody fusion proteins |
| AU2023338694A1 (en) * | 2022-09-08 | 2025-04-03 | Cugene Inc. | Novel pd1-targeted il-15 immunocytokine and vitokine fusions |
| WO2024216170A2 (en) * | 2023-04-12 | 2024-10-17 | Cytomx Therapeutics, Inc. | Activatable cytokine constructs and related compositions and methods |
| WO2025085744A1 (en) * | 2023-10-18 | 2025-04-24 | Memorial Sloan-Kettering Cancer Center | Fusion polypeptides and uses thereof |
| WO2025180355A1 (zh) * | 2024-02-27 | 2025-09-04 | 江苏奥赛康生物医药有限公司 | Il-15前药与免疫检查点抑制剂的组合 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9912350D0 (en) * | 1999-05-26 | 1999-07-28 | European Molecular Biology Lab Embl | Modified cytokine |
| FI117667B (fi) * | 2001-07-05 | 2007-01-15 | Univ Zuerich | Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä |
| ES2327830T3 (es) * | 2002-03-29 | 2009-11-04 | Schering Corporation | Anticuerpos monoclonales humanos anti-interleuquina-5 y metodos y composiciones que los contienen. |
| US20110178279A1 (en) * | 2009-08-03 | 2011-07-21 | Williams John C | Development of masked therapeutic antibodies to limit off-target effects: application to anti-egfr antibodies |
| US20100189651A1 (en) * | 2009-01-12 | 2010-07-29 | Cytomx Therapeutics, Llc | Modified antibody compositions, methods of making and using thereof |
| JP5861223B2 (ja) * | 2009-02-23 | 2016-02-16 | サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. | プロタンパク質およびその使用方法 |
| GB201203442D0 (en) * | 2012-02-28 | 2012-04-11 | Univ Birmingham | Immunotherapeutic molecules and uses |
| WO2016004383A1 (en) * | 2014-07-03 | 2016-01-07 | City Of Hope | Tumor-selective ctla-4 antagonists |
| WO2016210447A1 (en) * | 2015-06-26 | 2016-12-29 | University Of Southern California | Masking chimeric antigen receptor t cells for tumor-specific activation |
| WO2017201352A1 (en) * | 2016-05-18 | 2017-11-23 | Modernatx, Inc. | Mrna combination therapy for the treatment of cancer |
| CN110214147A (zh) * | 2016-10-14 | 2019-09-06 | Xencor股份有限公司 | IL15/IL15Rα异源二聚体FC-融合蛋白 |
| KR20190102259A (ko) * | 2017-01-10 | 2019-09-03 | 인트렉손 코포레이션 | 신규의 유전자 스위치 발현 시스템을 통한 폴리펩티드의 발현 조절 |
-
2019
- 2019-12-13 AU AU2019395266A patent/AU2019395266A1/en not_active Abandoned
- 2019-12-13 CA CA3121813A patent/CA3121813A1/en active Pending
- 2019-12-13 US US17/413,786 patent/US20230045048A1/en active Pending
- 2019-12-13 EP EP19897286.1A patent/EP3893917A4/en active Pending
- 2019-12-13 CN CN201980082406.XA patent/CN114746105A/zh active Pending
- 2019-12-13 JP JP2021534270A patent/JP7557465B2/ja active Active
- 2019-12-13 KR KR1020217018990A patent/KR102911817B1/ko active Active
- 2019-12-13 WO PCT/US2019/066287 patent/WO2020123980A1/en not_active Ceased
-
2024
- 2024-09-13 JP JP2024159011A patent/JP2024175026A/ja active Pending